RBDC backs Robinson Healthcare MBO

The development capital provider has led the £22m secondary buyout from 3i of the healthcare products manufacturer.

Royal Bank Development Capital (RBDC), the arm of The Royal Bank of Scotland Equity Finance unit that invests in £2m – £20m businesses, has backed the secondary management buyout of Robinson Healthcare Ltd from 3i and the Robinson family.

The transaction, valued at £22m, sees RBDC invest in a business that has grown significantly in the last few years and now has annual turnover of £33m. It is one of the UK’s leading manufacturers and distributors of personal care, woundcare and animal healthcare products.

The management buyout team was led by Terry Watson, who was appointed executive chairman of the company fifteen months ago

Bank of Scotland provided senior debt and working capital facilities. The deal was originated and led by Tenon Livingstone Guarantee in Nottingham.